Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05491213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TELESCOPE- TELEhealth Shared Decision-making COaching

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Primary completion date changed from estimate of May 31, 2026 to Apr 2, 2026
    • Study completion pushed from Jan 31, 2027 to Sep 16, 2027
    • Eligibility criteria expanded, about 18 words
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 2 of 2 entries
  2. Primary completion date: Jun 30, 2027 to May 31, 2026
    • Study completion date: Oct 31, 2027 to Jan 31, 2027
    v11
  3. Primary completion date: Dec 31, 2026 to Jun 30, 2027v10 Show 4 more changesShow less
    • Enrollment target: 420 to 594
    • Study completion date: Dec 31, 2027 to Oct 31, 2027
    • Secondary endpoints: 1 to 2
    • Eligibility criteria shortened, about 2 words
  4. Primary completion date: Dec 31, 2025 to Dec 31, 2026v9 Show 4 more changesShow less
    • Enrollment target: 400 to 420
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    • Eligibility criteria revised
    • Study sites revised (2)
  5. Primary completion date: Dec 31, 2026 to Dec 31, 2025
    • Enrollment target: 420 to 400
    • Study completion date: Dec 31, 2027 to Dec 31, 2026
    • Eligibility criteria revised
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Site contacts updated at 1 of 2 sitesv7
  2. Re-verified, no change to tracked fieldsv6
  3. Primary endpoint revised
    • Study sites: 1 to 2
    • Eligibility criteria expanded, about 1 word
    • Study description shortened, about 1 word
    v5
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Start date changed from estimate of Apr 3, 2023 to Feb 14, 2023
    • Eligibility criteria revised
    • Site details revised
    • Collaborators: 1 to 2
  5. Start date: Feb 28, 2023 to Apr 3, 2023v3 Show 4 more changesShow less
    • Primary completion date: Jun 10, 2027 to Dec 31, 2026
    • Study completion date: Oct 10, 2027 to Dec 31, 2027
    • Eligibility criteria revised
    • Site contact updated
  6. Start date: Sep 30, 2022 to Feb 28, 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).
Trial Details
NCT Number NCT05491213
Lead Sponsor Rutgers, The State University of New Jersey
Collaborators: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Lung Neoplasms
Related terms Lung Neoplasms
Enrollment 594 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov